Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qiyao Xiaoke (also known as Qiyao Xiaoke Capsule or QXC) is a traditional Chinese medicine formulation designed to invigorate qi and nourish yin. It is primarily used for the management of type 2 pre-diabetes and diabetes mellitus. Clinical studies indicate that when combined with lifestyle interventions, it can improve fasting and postprandial insulin secretion in patients with type 2 pre-diabetes, regulate glycolipid metabolism, and enhance glycemic control[1][3]. The mechanism of action is believed to involve modulation of insulin secretion and improvement in metabolic parameters; however, the precise molecular targets are not fully elucidated due to its multi-component herbal nature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qiyao Xiaoke.